期刊文献+

选择耐多药结核病化疗方案的若干问题 被引量:6

Issues in selection of treatment regimen for multidrug-resistant tuberculosis
下载PDF
导出
摘要 介绍MDR-TB化学治疗方案设计的基本原则、抗结核药物组成、化疗药物的使用频次及剂量、化疗方案疗程、化疗方案的推荐及化疗方案的调整等,供广大同道借鉴。 The following topics relate to the treatment of multidrug-resistant tuberculosis (MDR-TB) were discussed in this paper: the essential principles for the design of treatment regimens, selection of the anti-tuberculosis drugs, frequency and dosage of the use of anti-tuberculosis drugs, duration of the treatment regimens, the recommended treatment regimens and the adjustment of treatment.
出处 《中国防痨杂志》 CAS 2014年第7期521-524,共4页 Chinese Journal of Antituberculosis
基金 中国全球基金结核病项目(CHN-S10-G14-T)
关键词 结核 药物疗法 结核 抗多种药物性 药物疗法 临床方案 Tuberculosis/drug therapy Tuberculosis, multidrug-resistant/drug therapy Clinical protocols
  • 相关文献

参考文献15

二级参考文献122

共引文献126

同被引文献97

  • 1宋凯.咳痰时间、痰标本性状与涂片抗酸杆菌检出关系分析[J].中国防痨杂志,2008,30(5):414-416. 被引量:17
  • 2李红,唐神结,史祥,崔海燕,顾瑾,杨妍,何娅,桂徐蔚,方勇,郝晓辉,蒋瑞华.全血γ-干扰素释放试验对涂阴肺结核诊断价值的研究[J].中华临床医师杂志(电子版),2012,6(16):4894-4897. 被引量:52
  • 3钟佑洁,陈丽君,赵陵波.福建大学城周边农村妇女心理健康现状调查研究[J].中国健康心理学杂志,2007,15(2):185-187. 被引量:4
  • 4中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年)[M].北京:人民卫生出版社,2010.25-52.
  • 5Zhao Y,Xu S,Wang L,et al.National survey of dru-resistant tuberculosis in China.N Engl J Med,2012,366 (23):2161-2170.
  • 6World Health Organization.Global tuberculosis report 2013.WHO/HTM/TB/2013.11.Geneva:World Health Organization,2013.
  • 7World Health Organization.Commercial serodiagnostic tests for diagnosis of tuberculosis policy statement.WHO/HTM/TB/2011.5.Geneva:World Health Organization,2011.
  • 8Mazurek GH,Jereb J,Vernon A,et al.Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection United States,2010.MMWR Recomm Rep,2010,59 (RR5):1-25.
  • 9World Health Organization.Rapid implementation of the Xpert Mtb/RIF diagnostic test.WHO/HTM/TB/2011.2.Geneva:World Health Organization,2011.
  • 10World Health Organization.The use of molecular line probe assay for the detection of resistant to second line anti tuberculosis drugs.WHO/HTM/TB/2013.01.Geneva:World Health Organization,2013.

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部